BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Lunit's Groundbreaking AI Research Transforms Medical Pathology with Computer Vision, Presented at CVPR 2023

Lunit (KRX:328130.KQ), a leading global provider of AI-powered cancer diagnostic solutions, announced its participation in the Conference on Computer...

June 13, 2023 | News

HanAll Biopharma and Daewoong Pharmaceutical Co-invest in Vincere Biosciences for Parkinson's Disease Collaboration

HanAll Biopharma and Daewoong Pharmaceutical have co-invested in Vincere Biosciences. These mission-aligned companies are collaborating to develop small...

June 13, 2023 | News

DxVx Wins Government Project for Adult Disease Diagnostic Sensor Kit

DxVx announced that it won the national project, 'Korea-led K-Sensor Technology Development for Market Leadership' supported by the Ministry of Trade, Indu...

June 12, 2023 | News

BetaLife wins Cytiva’s first BioChallenge Competition in Southeast Asia

Cytiva’s BioChallenge aims to support the innovation of biotech startups. Cytiva recognizes the talent, resource and scalability constraints faced b...

June 07, 2023 | News

Samsung Biologics Hastens Timeline for New Plant, Aiming for April 2025 Launch

Samsung Biologics will maintain the world's largest biomanufacturing capacity at 784,000 liters upon completion of the newest plant- Key features of Plant ...

June 07, 2023 | News

Lunit & Capio S:t Göran Hospital Collaborate for AI-Powered Mammography Analysis

Lunit (KRX:328130.KQ), a leading global provider of AI-powered cancer diagnostic solutions, today announced the signing of a supply and license agree...

June 06, 2023 | News

Gencurix Announces Clinical Research Results At ASCO 2023

Gencurix (KOSDAQ #229000), a leading provider of cancer molecular diagnostics, announced the release of clinical research results directly compa...

June 06, 2023 | News

Seegene Obtains IVDR Certification for 30 Diagnostic Assays

Seegene certifies diagnostic assays for digestive, respiratory, women's diseases, and human papillomavirus to meet IVDR requirements New regulation...

June 02, 2023 | News

GC Biopharma Licensed to Build Plasma Fractionation Plant in Indonesia

GC Biopharma, a South Korean biopharmaceutical company, announced on Jun. 1st that it has successfully obtained final approval from the Indonesia...

June 02, 2023 | News

Merck Study: mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers

87% of respondents deemed mRNA a key modality for the future More than 60% of vaccine makers surveyed plan revamp or new facilities for mRNA m...

June 01, 2023 | News

Lunit and the JNCCHE Partner in AI Pathology to Advance Precision Oncology

Lunit (KRX:328130.KQ), a global provider of AI-powered cancer diagnostic solutions, today announced collaboration with the National Cancer Center...

May 31, 2023 | News

HanAll Biopharma, Daewoong Pharmaceutical, and NurrOn Pharma Collaborate on Parkinson's Therapy

HanAll Biopharma Co., Ltd. (KRX: 009420.KS) and Daewoong Pharmaceutical Co., Ltd. (KRX: 069620.KS) announced that they have entered into a co-developm...

May 26, 2023 | News

Lunit's AI-Biomarker Platform Shows Predictive Value at ASCO 2023

Lunit (KRX:328130.KQ), a global leader of AI-powered cancer diagnostics and therapeutics solutions, is set to make a significant impact at the American Soc...

May 26, 2023 | News

Daewoong Pharmaceutical Reveals Bersiporocin's Antifibrotic Mechanism

Daewoong Pharmaceutical (CEO Lee Chang-jae and Jeon Sengho) announced on the 25th that the molecular mechanism behind safety and efficacy of Bersiporo...

May 26, 2023 | News

Stay Connected